“Net-zero energy buildings generate as much energy as they use — a model that’s gaining traction as green products and systems become more common. A report earlier this year from Navigant expects the North American net-zero energy market to increase 38.4% from 2014 to a value of $127 billion by 2035.
One reason for this growth, according to Navigant, is the prevalence of technology that helps buildings meet such stringent energy-consumption requirements. Those include chilled-beam systems, more and better insulation, energy-efficient facades and improved controls for monitoring daylight levels and space occupancy. All that, in turn, is helping to bring the related methods and systems into local and state building codes — another driver of continued adoption of net-zero construction”.
“In this emotional talk, Carrie Wilkerson encourages us to define success for ourselves and no one else.
TEDx video included in this article:
Talking to a is like magic--the minutes fly by, your brain lights up, and you feel closely bonded to another human mind. No wonder so many of us want to master the seemingly mysterious ability to and really connect.
But unless you're naturally gifted with and wit, even holding up your end of a conversation can feel daunting. Learning not only to , but also to guide a conversation and bring the best out of others has to be an tough skill that makes years to master, right?
Nope, responds public radio host . In the course of her career she's interviewed thousands of people from all walks of life and learned that sparking a great conversation is really a matter of a few simple habits that anyone can learn. She shared her secrets in a TEDx talk a few years back.
To date, much of the research on prison education is centered on the correlation between prison education and recidivism—the tendency of an individual to reoffend. A 2013 meta-analysis by the RAND Corporation, in conjunction with the U.S. Department of Justice, found that incarcerated people who participated in correctional education programs have 43 percent lower odds of recidivating than those who did not. Furthermore, those who participated in such programs were 13 percent more likely to land post-release employment than those who had not. That number would likely be higher if discrimination against the formerly incarcerated weren’t so profound.
A new drug shows promise in its ability to target one of the most common and sinister mutations of acute myeloid leukemia (AML), according to researchers. In a first-in-human study, researchers treated relapsed patients with gilteritinib, an FLT3 inhibitor, and found it was a well-tolerated drug that led to frequent and more-sustained-than-expected clinical responses, almost exclusively in patients with this mutation.